A limitation of fluorescence in situ hybridization (FISH) assays targeting sex chromosomes for monitoring of early relapse after transplantation [2]

Transplantation

Volumn 71, Issue 4, 2001, Pages 581-583

  Kishi, Yukiko ^a,b,c,d,e   Kami, Masahiro ^a,b,c,d,e   Kogi, Mieko ^a,b,c,d,e   Oki, Yasuhiro ^a,b,c,d,e   Machida, Utako ^a,b,c,d,e   Kanda, Yoshinobu ^a,b,c,d,e   Ueyama, Jun Ichi ^a,b,c,d,e   Morinaga, Shin Ichi ^a,b,c,d,e   Muto, Yoshitomo ^a,b,c,d,e  

^a TORANOMON HOSPITAL   (Japan)

^b OTSUKA PHARMACEUTICAL CO LTD   (Japan)

^c Institute of Basic Medical Sciences   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

^e NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; BONE MARROW TRANSPLANTATION; CASE REPORT; CHROMOSOME; CHRONIC MYELOID LEUKEMIA; CYTOGENETICS; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN CELL; KARYOTYPE; LETTER; MALE; PRIORITY JOURNAL; RELAPSE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEX CHROMOSOME;

EID: 0035956943     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200102270-00019     Document Type: Letter

References (8)

1. Cytogenetic analysis using quantitative, high-sensitivity, fluorescence hybridization
2. Minimal residual disease after allogeneic bone marrow transplantation for chronic myeloid leukaemia: A metaphase-FISH study
3. Detection of minimal residual disease in an AML patient with trisomy 8 using interphase fish
4. Evaluation of minimal residual disease by interphase FISH in multiple myeloma: Does complete remission exist?
5. Fluorescence in situ hybridization (FISH) on peripheral blood smears for monitoring Philadelphia chromosome-positive chronic myeloid leukemia (CML) during interferon treatment: A new strategy for remission assessment
6. Fluorescence in situ hybridization with X and Y chromosome probes for cytogenetic studies on bone marrow cells after opposite sex transplantation
7. Loss of the Y chromosome in acute myelogenous leukemia: A report of 13 patients
8. Loss of Y chromosome. An age-related event or a cytogenetic marker of a malignant clone?